{"id":"W4385477402","doi":"10.1182/bloodadvances.2023010628","title":"Matching-adjusted indirect comparison of the pelabresib-ruxolitinib combination vs JAKi monotherapy in myelofibrosis","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; Celgene; MorphoSys; Astellas Pharma; Galecto; Sierra Oncology; Incyte; CTI Biopharma; Constellation Pharmaceuticals; Astex Pharmaceuticals; Jazz Pharmaceuticals; AOP Orphan; GlaxoSmithKline","keywords":"Ruxolitinib; Myelofibrosis; Matching (statistics); Medicine; Internal medicine; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01377078,0.002001659,0.004742248,0.0009960775,0.0003476365,0.001355157,0.001766785,0.001725143,0.01159429],"category_scores_gemma":[0.02488365,0.0006329966,0.01310137,0.0009512817,0.0007364338,0.001148555,0.001772096,0.002540264,0.0007472702],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009508255,"about_ca_system_score_gemma":0.0009379971,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002334754,"about_ca_topic_score_gemma":0.001842338,"domain_scores_codex":[0.9788154,0.01571541,0.001068651,0.002118109,0.001320529,0.0009618447],"domain_scores_gemma":[0.9869304,0.00891897,0.001631996,0.001527722,0.0006297242,0.0003613431],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.6901774,0.002354015,0.02608244,0.006192067,0.1925782,0.0004087062,0.000262452,0.01199641,0.004125049,0.00251998,0.004244728,0.05905847],"study_design_scores_gemma":[0.1859712,0.1720054,0.1895765,0.001526257,0.3392741,0.001199067,0.0007815218,0.06324141,0.01089427,0.01573933,0.01925569,0.0005353804],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9383699,0.01755594,0.02129694,0.000740111,0.002518682,0.003087588,0.008380905,0.0003619553,0.007687933],"genre_scores_gemma":[0.9834626,0.0008612089,0.00733253,0.0007178585,0.0001650298,0.002580349,0.002130977,0.00007707971,0.002672231],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01377078,"threshold_uncertainty_score":0.0728277,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02895329108079735,"score_gpt":0.3213575054599074,"score_spread":0.29240421437911,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}